Privia Health Is Maintained at Buy by Stifel

Privia Health Is Maintained at Buy by Stifel

Dow JonesMay 1 21:32

Stifel Maintains Buy on Privia Health Gr, Lowers Price Target to $24

Stifel analyst Craig Jones maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $28 to $24.

BenzingaMay 1 21:22

Privia Health Initiated at Buy by Citigroup

Privia Health Initiated at Buy by Citigroup

Dow JonesApr 22 21:11

Citigroup Initiates Coverage On Privia Health Gr With Buy Rating, Announces Price Target of $25

Citigroup analyst Daniel Grosslight initiates coverage on Privia Health Gr with a Buy rating and announces Price Target of $25.

Analyst UpgradesApr 22 21:01

Barclays Sticks to Its Hold Rating for Privia Health Group (PRVA)

TipRanksApr 15 16:26

Privia Health Group, Inc. (NASDAQ:PRVA) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Privia Health Group (NASDAQ:PRVA) has had a rough month with its share price down 15%. However, stock prices are usually driven by a company's financials over the long term, which in this case look

Simply Wall StApr 10 20:19